Christopher Nolan is working on an adaption of Homer's epic poem "Odyssey" though it is not yet known how he plans to adapt ...

Investing.com -- Gilead Sciences shares dropped more than 3% Wednesday following a Wall Street Journal report that the Health ...

Oppenheimer called the expected M&A rebound under the Trump administration “delayed or cancelled” and downgraded to "perform" ...

Oppenheimer said on Wednesday it no longer expects growth in U.S. investment banking revenue this year and slashed its ...

Retail investors remained bearish on Goldman Sachs Group Inc (GS) after Oppenheimer analyst Chris Kotowski reportedly ...

Oppenheimer downgraded Carlyle, Jefferies and Goldman Sachs to "perform" from "outperform" and said it now expects investment ...

Colin Farrell, Andrew Scott and Cillian Murphy followed behind, all making the top five. Colin led in the number of award ...

Tiemann Investment Advisors LLC reduced its stake in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 1.2% in the ...

David Bohm was a brilliant physicist. In the latter part of World War II, when he was just a graduate student, his PhD ...

Oppenheimer analyst Matthew Biegler lowered the firm’s price target on Olema Oncology (OLMA) to $25 from $30 but keeps an Outperform rating on ...

Leaders from Pennant Group, Inc. (Nasdaq: PNTG), the parent company of a network of home health, hospice, and senior living ...

From checking in amid the L.A. fires to supporting each other's careers, Quaid says the star-studded cast still chats ...